Eagle Brand

Eagle Pharmaceuticals is a specialty pharmaceutical company focused on developing and commercializing innovative medicines that address significant unmet needs in oncology, critical care, and orphan diseases. The company utilizes its expertise in formulation and development to improve upon existing drug therapies, often through the 505(b)(2) regulatory pathway. Its commercial portfolio includes key products such as Ryanodex for malignant hyperthermia, Belrapzo for chronic lymphocytic leukemia, and Pemfexy for non-small cell lung cancer. Eagle is also advancing a diverse pipeline, including treatments for exertional heat stroke and various oncology indications. By optimizing drug delivery and patient outcomes, the company aims to provide high-value solutions to the healthcare community.